Insider Transactions in Q1 2022 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-2.48%
|
$180,000
$90.0 P/Share
|
|
Mar 28
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.43%
|
$0
$0.46 P/Share
|
|
Mar 16
2022
|
Andrew Hykes President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.62%
|
$0
$0.43 P/Share
|
|
Mar 16
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Direct |
7,000
-2.87%
|
$560,000
$80.18 P/Share
|
|
Mar 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.68%
|
$562,500
$75.94 P/Share
|
|
Mar 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.3%
|
$0
$0.46 P/Share
|
|
Mar 07
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-0.79%
|
$5,760,000
$96.42 P/Share
|
|
Mar 07
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.01%
|
$0
$0.43 P/Share
|
|
Mar 03
2022
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-5.41%
|
-
|
|
Mar 01
2022
|
Robert Keith Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,191
+50.0%
|
-
|
|
Mar 01
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
13,696
-1.03%
|
$1,232,640
$90.74 P/Share
|
|
Mar 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2
-0.0%
|
$180
$90.0 P/Share
|
|
Mar 01
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2
+0.0%
|
$0
$0.46 P/Share
|
|
Feb 28
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
6,304
-1.79%
|
$567,360
$90.05 P/Share
|
|
Feb 28
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,998
-2.46%
|
$359,820
$90.01 P/Share
|
|
Feb 28
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,998
+4.63%
|
$0
$0.46 P/Share
|
|
Feb 24
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
4,172
-0.05%
|
$333,760
$80.06 P/Share
|
|
Feb 23
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
100
-0.0%
|
$8,000
$80.0 P/Share
|
|
Feb 17
2022
|
Thomas Tu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,936
+20.3%
|
-
|
|
Feb 17
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,936
+18.52%
|
-
|
|
Feb 17
2022
|
Andrew Hykes President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,879
+14.37%
|
-
|
|
Feb 17
2022
|
William Hoffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,708
+6.98%
|
-
|
|
Feb 16
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
8,993
-0.23%
|
$719,440
$80.06 P/Share
|
|
Feb 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-5.11%
|
$592,500
$79.04 P/Share
|
|
Feb 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.06%
|
$0
$0.46 P/Share
|
|
Feb 15
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
335
-0.01%
|
$26,800
$80.01 P/Share
|
|
Feb 09
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
400
-0.01%
|
$32,000
$80.06 P/Share
|
|
Feb 07
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.34%
|
$2,190,000
$73.48 P/Share
|
|
Feb 07
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.03%
|
$0
$0.43 P/Share
|
|
Feb 01
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.83%
|
$370,000
$74.08 P/Share
|
|
Jan 18
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.8%
|
$380,000
$76.91 P/Share
|
|
Jan 18
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.59%
|
$570,000
$76.9 P/Share
|
|
Jan 18
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.1%
|
$0
$0.46 P/Share
|
|
Jan 04
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.92%
|
$2,850,000
$95.58 P/Share
|
|
Jan 01
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-0.4%
|
$24,934
$91.27 P/Share
|
|
Jan 01
2022
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
411
-0.3%
|
$37,401
$91.27 P/Share
|
|
Jan 01
2022
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
548
-0.11%
|
$49,868
$91.27 P/Share
|
|
Jan 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-0.47%
|
$24,934
$91.27 P/Share
|